AEON Biopharma (AEON) Total Liabilities (2020 - 2026)
AEON Biopharma (AEON) posted Total Liabilities of $60.6 million for Q4 2025, up 111.8% sequentially from $28.6 million in Q3 2025, and up 91.06% YoY from $31.7 million in Q4 2024.
AEON Biopharma (AEON) Total Liabilities (2020 - 2026) Analysis & Trends
AEON Biopharma has reported Total Liabilities for 6 years, with the latest figure at $60.6 million in Q4 2025.
- Quarterly Total Liabilities rose 91.06% year-over-year to $60.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $60.6 million (up 91.06% YoY) and the FY2025 annual result came in at $60.6 million, up 91.06% from the prior year.
- Total Liabilities rose to $60.6 million in Q4 2025 per AEON's latest filing, from $28.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $201.4 million in Q1 2024 and troughed at $7.9 million in Q1 2023.
- A 5-year average of $51.9 million and a median of $26.3 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities jumped 29905.01% in 2021, then slumped 87.53% in 2025.
- Over 5 years, Total Liabilities stood at $17.9 million in 2021, then jumped by 701.16% to $143.2 million in 2022, then climbed by 11.62% to $159.9 million in 2023, then sank by 80.17% to $31.7 million in 2024, then surged by 91.06% to $60.6 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $60.6 million, $28.6 million, and $27.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - | 21.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.27 Mn |
| Dec 31, 2025 | 60.59 Mn |
| Sep 30, 2025 | 28.61 Mn |
| Jun 30, 2025 | 27.51 Mn |
| Mar 31, 2025 | 25.12 Mn |
| Dec 31, 2024 | 31.71 Mn |
| Sep 30, 2024 | 36.09 Mn |
| Jun 30, 2024 | 33.68 Mn |
| Mar 31, 2024 | 201.41 Mn |
| Dec 31, 2023 | 159.89 Mn |
| Sep 30, 2023 | 146.02 Mn |
| Jun 30, 2023 | 12.05 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 143.24 Mn |
| Sep 30, 2022 | 11.97 Mn |
| Jun 30, 2022 | 12.80 Mn |
| Mar 31, 2022 | 14.80 Mn |
| Dec 31, 2021 | 17.88 Mn |
| Sep 30, 2021 | 22.20 Mn |
| Jun 30, 2021 | 24.45 Mn |